Glioma immunotherapy group
1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma
(
- Contribution to journal › Article
-
Mark
Prolonged and intense neuroinflammation after severe traumatic brain injury assessed by cerebral microdialysis with 300 kDa membranes
(
- Contribution to journal › Article
-
Mark
Comparison of perimetric 24-2 and 30-2 test patterns in detecting visual field defects in patients with tumours in the pituitary region
2023) In Acta Ophthalmologica(
- Contribution to journal › Article
-
Mark
Visual acuity in patients with non-functioning pituitary adenoma : Prognostic factors and long-term outcome after surgery
(
- Contribution to journal › Article
- 2022
-
Mark
Intratumoral administration of the antisecretory peptide AF16 cures murine gliomas and modulates macrophage functions
(
- Contribution to journal › Article
-
Mark
Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization
2022) In Proceedings of the National Academy of Sciences of the United States of America 119(9). p.1-11(
- Contribution to journal › Article
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
(
- Contribution to journal › Article
-
Mark
Novel methods of malignant brain tumor treatment utilizing the tumor microenvironment
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Non-functioning pituitary microadenoma in children and adolescents : Is follow-up with diagnostic imaging necessary?
2022) In Endocrine(
- Contribution to journal › Article
- 2021
-
Mark
Circular rnas in hedgehog signaling activation and hedgehog‐mediated medulloblastoma tumors
(
- Contribution to journal › Article